Synairgen Plc Is A Uk Based Biotechnology Company Focused On Respiratory Drug Discovery And Developmentfounded In 200 By Professors From Theuniversity Of Southamptonthecompany Aims To Translateresearch Insights Into Clinical Treatments For Viral Respiratory Diseasesheadquartered In Southamptonsynairgen Employs 6 Peopleand Has Its Roots In Immunophysiology Research Dating Back To The1970S Thecompany Specializes In Inhaled Therapies That Enhancethelungsantiviral Defensemechanismsparticularly Through Its Flagship Productsng001This Inhaled Formulation Of Interferon Betaifn I Is Designed To Improveimmuneresponses In Thelungs Against Various Respiratory Virusesincluding Rsvrhinovirusand Sars Cov 2Synairgen Conducts Preclinical Research And Clinical Trials To Evaluatetheefficacy Of Sng001Targeting High Risk Populations And Hospitalized Patients With Severeviral Respiratory Infectionsthecompanyaes Research Driven Approach Leverages Decades Of Expertisein Immunophysiology To Develop Targeted Therapies
